Literature DB >> 1972037

Cellular and developmental properties of fetal hematopoietic stem cells.

C T Jordan1, J P McKearn, I R Lemischka.   

Abstract

We have characterized the fetal totipotent hematopoietic stem cell using a novel strategy that integrates physical analysis of cell properties and genetic analysis of in vivo developmental behavior. This approach allows the simultaneous isolation and in vivo characterization of any stem cell population. Using this procedure we demonstrate that a cell surface marker, recognized by monoclonal antibody AA4.1, defines 0.5%-1.0% of fetal liver tissue that contains the entire hierarchy of primitive hematopoietic cells. The AA4.1+ subpopulation includes multipotential in vitro progenitors, CFU-S cells, and lymphoid-myeloid stem cells that function to yield permanent and oligoclonal blood systems. Further fractionation of these cells by analysis of density, fibronectin binding, and surface antigen distribution has defined 0.1%-0.2% of fetal liver that contains the totipotent stem cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972037     DOI: 10.1016/0092-8674(90)90061-i

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  The power of stem cells reconsidered?

Authors:  I Lemischka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  In vitro differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in vivo.

Authors:  J C Gutierrez-Ramos; R Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  The same exhaustible multilineage precursor produces both myeloid and lymphoid cells as early as 3-4 weeks after marrow transplantation.

Authors:  D E Harrison; R K Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

4.  Characterization of purified intraembryonic hematopoietic stem cells as a tool to define their site of origin.

Authors:  Julien Y Bertrand; Sébastien Giroux; Rachel Golub; Michèle Klaine; Abdelali Jalil; Laurent Boucontet; Isabelle Godin; Ana Cumano
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

5.  Purification and characterization of retrovirally transduced hematopoietic stem cells.

Authors:  L M Spain; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus-infected hemopoietic stem cells.

Authors:  X D Han; P M Wong; S W Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 7.  Stem cell plasticity: a rare cell, not a rare event.

Authors:  Yoon-Young Jang; Saul J Sharkis
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 8.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 9.  The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors.

Authors:  Wataru Kimura; Hesham A Sadek
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

10.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

Authors:  J C van der Loo; X Xiao; D McMillin; K Hashino; I Kato; D A Williams
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.